|
Fusion Gene Summary | |
Fusion Gene ORF analysis | |
Fusion Genomic Features | |
Fusion Protein Features | |
Fusion Gene Sequence | |
Fusion Gene PPI analysis | |
Related Drugs | |
Related Diseases |
Fusion gene:NAA30-TERT (FusionGDB2 ID:56637) |
Fusion Gene Summary for NAA30-TERT |
Fusion gene summary |
Fusion gene information | Fusion gene name: NAA30-TERT | Fusion gene ID: 56637 | Hgene | Tgene | Gene symbol | NAA30 | TERT | Gene ID | 122830 | 7015 |
Gene name | N-alpha-acetyltransferase 30, NatC catalytic subunit | telomerase reverse transcriptase | |
Synonyms | C14orf35|MAK3|Mak3p|NAT12|NAT12P | CMM9|DKCA2|DKCB4|EST2|PFBMFT1|TCS1|TP2|TRT|hEST2|hTRT | |
Cytomap | 14q22.3 | 5p15.33 | |
Type of gene | protein-coding | protein-coding | |
Description | N-alpha-acetyltransferase 30N-acetyltransferase 12 (GCN5-related, putative)N-acetyltransferase MAK3 homolognatC catalytic subunitputative N-acetyltransferase | telomerase reverse transcriptasetelomerase catalytic subunittelomerase-associated protein 2 | |
Modification date | 20200313 | 20200329 | |
UniProtAcc | Q147X3 | . | |
Ensembl transtripts involved in fusion gene | ENST00000555166, ENST00000556492, ENST00000554703, | ENST00000310581, ENST00000296820, ENST00000334602, ENST00000508104, ENST00000522877, | |
Fusion gene scores | * DoF score | 1 X 1 X 1=1 | 22 X 7 X 15=2310 |
# samples | 1 | 31 | |
** MAII score | log2(1/1*10)=3.32192809488736 | log2(31/2310*10)=-2.89755273102918 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context | PubMed: NAA30 [Title/Abstract] AND TERT [Title/Abstract] AND fusion [Title/Abstract] | ||
Most frequent breakpoint | NAA30(57866601)-TERT(1282739), # samples:3 | ||
Anticipated loss of major functional domain due to fusion event. | NAA30-TERT seems lost the major protein functional domain in Hgene partner, which is a essential gene due to the frame-shifted ORF. NAA30-TERT seems lost the major protein functional domain in Tgene partner, which is a CGC due to the frame-shifted ORF. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | NAA30 | GO:0017196 | N-terminal peptidyl-methionine acetylation | 19398576 |
Tgene | TERT | GO:0001172 | transcription, RNA-templated | 19701182 |
Tgene | TERT | GO:0006278 | RNA-dependent DNA biosynthetic process | 9398860 |
Tgene | TERT | GO:0007004 | telomere maintenance via telomerase | 9443919|16043710|17940095|19701182|21531765|29695869 |
Tgene | TERT | GO:0007005 | mitochondrion organization | 21937513 |
Tgene | TERT | GO:0010629 | negative regulation of gene expression | 11927518 |
Tgene | TERT | GO:0022616 | DNA strand elongation | 16043710 |
Tgene | TERT | GO:0030422 | production of siRNA involved in RNA interference | 19701182 |
Tgene | TERT | GO:0031647 | regulation of protein stability | 24415760|26194824 |
Tgene | TERT | GO:0032092 | positive regulation of protein binding | 24415760 |
Tgene | TERT | GO:0051000 | positive regulation of nitric-oxide synthase activity | 11927518 |
Tgene | TERT | GO:0070200 | establishment of protein localization to telomere | 25589350 |
Tgene | TERT | GO:0071897 | DNA biosynthetic process | 9398860|19701182 |
Tgene | TERT | GO:1903704 | negative regulation of production of siRNA involved in RNA interference | 19701182 |
Tgene | TERT | GO:1904751 | positive regulation of protein localization to nucleolus | 24415760 |
Tgene | TERT | GO:2000773 | negative regulation of cellular senescence | 11927518 |
Fusion gene breakpoints across NAA30 (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene breakpoints across TERT (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene information from two resources (ChiTars 5.0 and ChimerDB 4.0) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChimerDB4 | GBM | TCGA-27-1835-01A | NAA30 | chr14 | 57866601 | + | TERT | chr5 | 1282739 | - |
ChimerDB4 | GBM | TCGA-27-1835-01A | NAA30 | chr14 | 57866601 | + | TERT | chr5 | 1282739 | - |
ChimerDB4 | GBM | TCGA-27-1835-01A | NAA30 | chr14 | 57866601 | - | TERT | chr5 | 1282739 | - |
Top |
Fusion Gene ORF analysis for NAA30-TERT |
Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
Frame-shift | ENST00000555166 | ENST00000310581 | NAA30 | chr14 | 57866601 | + | TERT | chr5 | 1282739 | - |
In-frame | ENST00000555166 | ENST00000296820 | NAA30 | chr14 | 57866601 | + | TERT | chr5 | 1282739 | - |
Frame-shift | ENST00000555166 | ENST00000334602 | NAA30 | chr14 | 57866601 | + | TERT | chr5 | 1282739 | - |
Frame-shift | ENST00000555166 | ENST00000508104 | NAA30 | chr14 | 57866601 | + | TERT | chr5 | 1282739 | - |
5CDS-intron | ENST00000555166 | ENST00000522877 | NAA30 | chr14 | 57866601 | + | TERT | chr5 | 1282739 | - |
Frame-shift | ENST00000556492 | ENST00000310581 | NAA30 | chr14 | 57866601 | + | TERT | chr5 | 1282739 | - |
In-frame | ENST00000556492 | ENST00000296820 | NAA30 | chr14 | 57866601 | + | TERT | chr5 | 1282739 | - |
Frame-shift | ENST00000556492 | ENST00000334602 | NAA30 | chr14 | 57866601 | + | TERT | chr5 | 1282739 | - |
Frame-shift | ENST00000556492 | ENST00000508104 | NAA30 | chr14 | 57866601 | + | TERT | chr5 | 1282739 | - |
5CDS-intron | ENST00000556492 | ENST00000522877 | NAA30 | chr14 | 57866601 | + | TERT | chr5 | 1282739 | - |
intron-3CDS | ENST00000554703 | ENST00000310581 | NAA30 | chr14 | 57866601 | + | TERT | chr5 | 1282739 | - |
intron-3CDS | ENST00000554703 | ENST00000296820 | NAA30 | chr14 | 57866601 | + | TERT | chr5 | 1282739 | - |
intron-3CDS | ENST00000554703 | ENST00000334602 | NAA30 | chr14 | 57866601 | + | TERT | chr5 | 1282739 | - |
intron-3CDS | ENST00000554703 | ENST00000508104 | NAA30 | chr14 | 57866601 | + | TERT | chr5 | 1282739 | - |
intron-intron | ENST00000554703 | ENST00000522877 | NAA30 | chr14 | 57866601 | + | TERT | chr5 | 1282739 | - |
ORFfinder result based on the fusion transcript sequence of in-frame fusion genes. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
ENST00000555166 | NAA30 | chr14 | 57866601 | + | ENST00000296820 | TERT | chr5 | 1282739 | - | 2540 | 342 | 999 | 1985 | 328 |
ENST00000556492 | NAA30 | chr14 | 57866601 | + | ENST00000296820 | TERT | chr5 | 1282739 | - | 3303 | 1105 | 46 | 1176 | 376 |
DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
ENST00000555166 | ENST00000296820 | NAA30 | chr14 | 57866601 | + | TERT | chr5 | 1282739 | - | 0.08426387 | 0.91573614 |
ENST00000556492 | ENST00000296820 | NAA30 | chr14 | 57866601 | + | TERT | chr5 | 1282739 | - | 0.017126534 | 0.9828735 |
Top |
Fusion Genomic Features for NAA30-TERT |
FusionAI prediction of the potential fusion gene breakpoint based on the pre-mature RNA sequence context (+/- 5kb of individual partner genes, total 20kb length sequence). FusionAI is a fusion gene breakpoint classifier based on convolutional neural network by comparing the fusion positive and negative sequence context of ~ 20K fusion gene data. From here, we can have the relative potentency of the 20K genomic sequence how individual sequnce will be likely used as the gene fusion breakpoints. |
Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | 1-p | p (fusion gene breakpoint) |
Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions. We integrated a total of 44 different types of human genomic feature loci information across five big categories including virus integration sites, repeats, structural variants, chromatin states, and gene expression regulation. More details are in help page. |
Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions that are ovelapped with the top 1% feature importance score regions. More details are in help page. |
Top |
Fusion Protein Features for NAA30-TERT |
Go to FGviewer for the breakpoints of chr14:57866601-chr5:1282739 - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. |
Main function of each fusion partner protein. (from UniProt) |
Hgene | Tgene |
NAA30 | . |
FUNCTION: Catalytic subunit of the N-terminal acetyltransferase C (NatC) complex. Catalyzes acetylation of the N-terminal methionine residues of peptides beginning with Met-Leu-Ala and Met-Leu-Gly. Necessary for the lysosomal localization and function of ARL8B sugeesting that ARL8B is a NatC substrate. {ECO:0000269|PubMed:19398576}. | FUNCTION: Might normally function as a transcriptional repressor. EWS-fusion-proteins (EFPS) may play a role in the tumorigenic process. They may disturb gene expression by mimicking, or interfering with the normal function of CTD-POLII within the transcription initiation complex. They may also contribute to an aberrant activation of the fusion protein target genes. |
Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | NAA30 | chr14:57866601 | chr5:1282739 | ENST00000556492 | + | 4 | 5 | 5_30 | 317.0 | 363.0 | Compositional bias | Note=Pro-rich |
Tgene | TERT | chr14:57866601 | chr5:1282739 | ENST00000296820 | 1 | 14 | 605_935 | 524.3333333333334 | 445.6666666666667 | Domain | Reverse transcriptase | |
Tgene | TERT | chr14:57866601 | chr5:1282739 | ENST00000310581 | 1 | 16 | 605_935 | 524.3333333333334 | 1133.0 | Domain | Reverse transcriptase | |
Tgene | TERT | chr14:57866601 | chr5:1282739 | ENST00000334602 | 1 | 15 | 605_935 | 524.3333333333334 | 1070.0 | Domain | Reverse transcriptase | |
Tgene | TERT | chr14:57866601 | chr5:1282739 | ENST00000508104 | 1 | 8 | 605_935 | 524.3333333333334 | 808.0 | Domain | Reverse transcriptase | |
Tgene | TERT | chr14:57866601 | chr5:1282739 | ENST00000296820 | 1 | 14 | 914_928 | 524.3333333333334 | 445.6666666666667 | Region | Note=Required for oligomerization | |
Tgene | TERT | chr14:57866601 | chr5:1282739 | ENST00000296820 | 1 | 14 | 936_1132 | 524.3333333333334 | 445.6666666666667 | Region | Note=CTE | |
Tgene | TERT | chr14:57866601 | chr5:1282739 | ENST00000310581 | 1 | 16 | 914_928 | 524.3333333333334 | 1133.0 | Region | Note=Required for oligomerization | |
Tgene | TERT | chr14:57866601 | chr5:1282739 | ENST00000310581 | 1 | 16 | 936_1132 | 524.3333333333334 | 1133.0 | Region | Note=CTE | |
Tgene | TERT | chr14:57866601 | chr5:1282739 | ENST00000334602 | 1 | 15 | 914_928 | 524.3333333333334 | 1070.0 | Region | Note=Required for oligomerization | |
Tgene | TERT | chr14:57866601 | chr5:1282739 | ENST00000334602 | 1 | 15 | 936_1132 | 524.3333333333334 | 1070.0 | Region | Note=CTE | |
Tgene | TERT | chr14:57866601 | chr5:1282739 | ENST00000508104 | 1 | 8 | 914_928 | 524.3333333333334 | 808.0 | Region | Note=Required for oligomerization | |
Tgene | TERT | chr14:57866601 | chr5:1282739 | ENST00000508104 | 1 | 8 | 936_1132 | 524.3333333333334 | 808.0 | Region | Note=CTE |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | NAA30 | chr14:57866601 | chr5:1282739 | ENST00000556492 | + | 4 | 5 | 214_362 | 317.0 | 363.0 | Domain | N-acetyltransferase |
Tgene | TERT | chr14:57866601 | chr5:1282739 | ENST00000296820 | 1 | 14 | 222_240 | 524.3333333333334 | 445.6666666666667 | Motif | Note=Bipartite nuclear localization signal | |
Tgene | TERT | chr14:57866601 | chr5:1282739 | ENST00000296820 | 1 | 14 | 328_333 | 524.3333333333334 | 445.6666666666667 | Motif | TFLY%3B involved in RNA binding | |
Tgene | TERT | chr14:57866601 | chr5:1282739 | ENST00000310581 | 1 | 16 | 222_240 | 524.3333333333334 | 1133.0 | Motif | Note=Bipartite nuclear localization signal | |
Tgene | TERT | chr14:57866601 | chr5:1282739 | ENST00000310581 | 1 | 16 | 328_333 | 524.3333333333334 | 1133.0 | Motif | TFLY%3B involved in RNA binding | |
Tgene | TERT | chr14:57866601 | chr5:1282739 | ENST00000334602 | 1 | 15 | 222_240 | 524.3333333333334 | 1070.0 | Motif | Note=Bipartite nuclear localization signal | |
Tgene | TERT | chr14:57866601 | chr5:1282739 | ENST00000334602 | 1 | 15 | 328_333 | 524.3333333333334 | 1070.0 | Motif | TFLY%3B involved in RNA binding | |
Tgene | TERT | chr14:57866601 | chr5:1282739 | ENST00000508104 | 1 | 8 | 222_240 | 524.3333333333334 | 808.0 | Motif | Note=Bipartite nuclear localization signal | |
Tgene | TERT | chr14:57866601 | chr5:1282739 | ENST00000508104 | 1 | 8 | 328_333 | 524.3333333333334 | 808.0 | Motif | TFLY%3B involved in RNA binding | |
Tgene | TERT | chr14:57866601 | chr5:1282739 | ENST00000296820 | 1 | 14 | 1_230 | 524.3333333333334 | 445.6666666666667 | Region | Note=RNA-interacting domain 1 | |
Tgene | TERT | chr14:57866601 | chr5:1282739 | ENST00000296820 | 1 | 14 | 231_324 | 524.3333333333334 | 445.6666666666667 | Region | Note=Linker | |
Tgene | TERT | chr14:57866601 | chr5:1282739 | ENST00000296820 | 1 | 14 | 301_538 | 524.3333333333334 | 445.6666666666667 | Region | Note=Required for oligomerization | |
Tgene | TERT | chr14:57866601 | chr5:1282739 | ENST00000296820 | 1 | 14 | 325_550 | 524.3333333333334 | 445.6666666666667 | Region | Note=RNA-interacting domain 2 | |
Tgene | TERT | chr14:57866601 | chr5:1282739 | ENST00000296820 | 1 | 14 | 376_521 | 524.3333333333334 | 445.6666666666667 | Region | Note=QFP motif | |
Tgene | TERT | chr14:57866601 | chr5:1282739 | ENST00000296820 | 1 | 14 | 397_417 | 524.3333333333334 | 445.6666666666667 | Region | Note=CP motif | |
Tgene | TERT | chr14:57866601 | chr5:1282739 | ENST00000296820 | 1 | 14 | 58_197 | 524.3333333333334 | 445.6666666666667 | Region | Note=GQ motif | |
Tgene | TERT | chr14:57866601 | chr5:1282739 | ENST00000310581 | 1 | 16 | 1_230 | 524.3333333333334 | 1133.0 | Region | Note=RNA-interacting domain 1 | |
Tgene | TERT | chr14:57866601 | chr5:1282739 | ENST00000310581 | 1 | 16 | 231_324 | 524.3333333333334 | 1133.0 | Region | Note=Linker | |
Tgene | TERT | chr14:57866601 | chr5:1282739 | ENST00000310581 | 1 | 16 | 301_538 | 524.3333333333334 | 1133.0 | Region | Note=Required for oligomerization | |
Tgene | TERT | chr14:57866601 | chr5:1282739 | ENST00000310581 | 1 | 16 | 325_550 | 524.3333333333334 | 1133.0 | Region | Note=RNA-interacting domain 2 | |
Tgene | TERT | chr14:57866601 | chr5:1282739 | ENST00000310581 | 1 | 16 | 376_521 | 524.3333333333334 | 1133.0 | Region | Note=QFP motif | |
Tgene | TERT | chr14:57866601 | chr5:1282739 | ENST00000310581 | 1 | 16 | 397_417 | 524.3333333333334 | 1133.0 | Region | Note=CP motif | |
Tgene | TERT | chr14:57866601 | chr5:1282739 | ENST00000310581 | 1 | 16 | 58_197 | 524.3333333333334 | 1133.0 | Region | Note=GQ motif | |
Tgene | TERT | chr14:57866601 | chr5:1282739 | ENST00000334602 | 1 | 15 | 1_230 | 524.3333333333334 | 1070.0 | Region | Note=RNA-interacting domain 1 | |
Tgene | TERT | chr14:57866601 | chr5:1282739 | ENST00000334602 | 1 | 15 | 231_324 | 524.3333333333334 | 1070.0 | Region | Note=Linker | |
Tgene | TERT | chr14:57866601 | chr5:1282739 | ENST00000334602 | 1 | 15 | 301_538 | 524.3333333333334 | 1070.0 | Region | Note=Required for oligomerization | |
Tgene | TERT | chr14:57866601 | chr5:1282739 | ENST00000334602 | 1 | 15 | 325_550 | 524.3333333333334 | 1070.0 | Region | Note=RNA-interacting domain 2 | |
Tgene | TERT | chr14:57866601 | chr5:1282739 | ENST00000334602 | 1 | 15 | 376_521 | 524.3333333333334 | 1070.0 | Region | Note=QFP motif | |
Tgene | TERT | chr14:57866601 | chr5:1282739 | ENST00000334602 | 1 | 15 | 397_417 | 524.3333333333334 | 1070.0 | Region | Note=CP motif | |
Tgene | TERT | chr14:57866601 | chr5:1282739 | ENST00000334602 | 1 | 15 | 58_197 | 524.3333333333334 | 1070.0 | Region | Note=GQ motif | |
Tgene | TERT | chr14:57866601 | chr5:1282739 | ENST00000508104 | 1 | 8 | 1_230 | 524.3333333333334 | 808.0 | Region | Note=RNA-interacting domain 1 | |
Tgene | TERT | chr14:57866601 | chr5:1282739 | ENST00000508104 | 1 | 8 | 231_324 | 524.3333333333334 | 808.0 | Region | Note=Linker | |
Tgene | TERT | chr14:57866601 | chr5:1282739 | ENST00000508104 | 1 | 8 | 301_538 | 524.3333333333334 | 808.0 | Region | Note=Required for oligomerization | |
Tgene | TERT | chr14:57866601 | chr5:1282739 | ENST00000508104 | 1 | 8 | 325_550 | 524.3333333333334 | 808.0 | Region | Note=RNA-interacting domain 2 | |
Tgene | TERT | chr14:57866601 | chr5:1282739 | ENST00000508104 | 1 | 8 | 376_521 | 524.3333333333334 | 808.0 | Region | Note=QFP motif | |
Tgene | TERT | chr14:57866601 | chr5:1282739 | ENST00000508104 | 1 | 8 | 397_417 | 524.3333333333334 | 808.0 | Region | Note=CP motif | |
Tgene | TERT | chr14:57866601 | chr5:1282739 | ENST00000508104 | 1 | 8 | 58_197 | 524.3333333333334 | 808.0 | Region | Note=GQ motif |
Top |
Fusion Gene Sequence for NAA30-TERT |
For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. To have fusion amino acid sequence, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
>In-frame_ENST00000555166_ENST00000296820_TCGA-27-1835-01A_NAA30_chr14_57866601_+_TERT_chr5_1282739_length(transcript)=2540nt_BP=342nt AGGCCCAGGAAACTTTACCCGGCCTAACAGCTGAGGCGCTTTACGGCGACGGCGGCTGAGTGAGAACCTTGGCGGCTGTGGAGGCTGCCG CGGCTGCGAAGGAGGCGGCGGCGGTGGCGGAGGAAGAGGAGTGGCGGCAGCGGCGGCGGGGACCCGTGCGGGGCCATGGTAGGGGAGGAG TGTGTAGGTGCCATCGTTTGCAAGTTGGATATGCACAAAAAGATGTTCCGCAGAGGTTATATAGCCATGTTAGCCGTGGATTCCAAATAC AGGAGAAATGGCATTGGTACTAACTTGGTTAAGAAAGCTATATATGCCATGGTTGAGGGAGACTGTGATGAGGGGTTGGCTGTGTTCCGG CCGCAGAGCACCGTCTGCGTGAGGAGATCCTGGCCAAGTTCCTGCACTGGCTGATGAGTGTGTACGTCGTCGAGCTGCTCAGGTCTTTCT TTTATGTCACGGAGACCACGTTTCAAAAGAACAGGCTCTTTTTCTACCGGAAGAGTGTCTGGAGCAAGTTGCAAAGCATTGGAATCAGAC AGCACTTGAAGAGGGTGCAGCTGCGGGAGCTGTCGGAAGCAGAGGTCAGGCAGCATCGGGAAGCCAGGCCCGCCCTGCTGACGTCCAGAC TCCGCTTCATCCCCAAGCCTGACGGGCTGCGGCCGATTGTGAACATGGACTACGTCGTGGGAGCCAGAACGTTCCGCAGAGAAAAGAGGG CCGAGCGTCTCACCTCGAGGGTGAAGGCACTGTTCAGCGTGCTCAACTACGAGCGGGCGCGGCGCCCCGGCCTCCTGGGCGCCTCTGTGC TGGGCCTGGACGATATCCACAGGGCCTGGCGCACCTTCGTGCTGCGTGTGCGGGCCCAGGACCCGCCGCCTGAGCTGTACTTTGTCAAGG TGGATGTGACGGGCGCGTACGACACCATCCCCCAGGACAGGCTCACGGAGGTCATCGCCAGCATCATCAAACCCCAGAACACGTACTGCG TGCGTCGGTATGCCGTGGTCCAGAAGGCCGCCCATGGGCACGTCCGCAAGGCCTTCAAGAGCCACGTCCTACGTCCAGTGCCAGGGGATC CCGCAGGGCTCCATCCTCTCCACGCTGCTCTGCAGCCTGTGCTACGGCGACATGGAGAACAAGCTGTTTGCGGGGATTCGGCGGGACGGG CTGCTCCTGCGTTTGGTGGATGATTTCTTGTTGGTGACACCTCACCTCACCCACGCGAAAACCTTCCTCAGGACCCTGGTCCGAGGTGTC CCTGAGTATGGCTGCGTGGTGAACTTGCGGAAGACAGTGGTGAACTTCCCTGTAGAAGACGAGGCCCTGGGTGGCACGGCTTTTGTTCAG ATGCCGGCCCACGGCCTATTCCCCTGGTGCGGCCTGCTGCTGGATACCCGGACCCTGGAGGTGCAGAGCGACTACTCCAGCTATGCCCGG ACCTCCATCAGAGCCAGTCTCACCTTCAACCGCGGCTTCAAGGCTGGGAGGAACATGCGTCGCAAACTCTTTGGGGTCTTGCGGCTGAAG TGTCACAGCCTGTTTCTGGATTTGCAGGTGAACAGCCTCCAGACGGTGTGCACCAACATCTACAAGATCCTCCTGCTGCAGGCGTACAGG TTTCACGCATGTGTGCTGCAGCTCCCATTTCATCAGCAAGTTTGGAAGAACCCCACATTTTTCCTGCGCGTCATCTCTGACACGGCCTCC CTCTGCTACTCCATCCTGAAAGCCAAGAACGCAGGGATGTCGCTGGGGGCCAAGGGCGCCGCCGGCCCTCTGCCCTCCGAGGCCGTGCAG TGGCTGTGCCACCAAGCATTCCTGCTCAAGCTGACTCGACACCGTGTCACCTACGTGCCACTCCTGGGGTCACTCAGGACAGCCCAGACG CAGCTGAGTCGGAAGCTCCCGGGGACGACGCTGACTGCCCTGGAGGCCGCAGCCAACCCGGCACTGCCCTCAGACTTCAAGACCATCCTG GACTGATGGCCACCCGCCCACAGCCAGGCCGAGAGCAGACACCAGCAGCCCTGTCACGCCGGGCTCTACGTCCCAGGGAGGGAGGGGCGG CCCACACCCAGGCCCGCACCGCTGGGAGTCTGAGGCCTGAGTGAGTGTTTGGCCGAGGCCTGCATGTCCGGCTGAAGGCTGAGTGTCCGG CTGAGGCCTGAGCGAGTGTCCAGCCAAGGGCTGAGTGTCCAGCACACCTGCCGTCTTCACTTCCCCACAGGCTGGCGCTCGGCTCCACCC CAGGGCCAGCTTTTCCTCACCAGGAGCCCGGCTTCCACTCCCCACATAGGAATAGTCCATCCCCAGATTCGCCATTGTTCACCCCTCGCC CTGCCCTCCTTTGCCTTCCACCCCCACCATCCAGGTGGAGACCCTGAGAAGGACCCTGGGAGCTCTGGGAATTTGGAGTGACCAAAGGTG TGCCCTGTACACAGGCGAGGACCCTGCACCTGGATGGGGGTCCCTGTGGGTCAAATTGGGGGGAGGTGCTGTGGGAGTAAAATACTGAAT >In-frame_ENST00000555166_ENST00000296820_TCGA-27-1835-01A_NAA30_chr14_57866601_+_TERT_chr5_1282739_length(amino acids)=328AA_start in transcript=999_stop in transcript=1985 MPWSRRPPMGTSARPSRATSYVQCQGIPQGSILSTLLCSLCYGDMENKLFAGIRRDGLLLRLVDDFLLVTPHLTHAKTFLRTLVRGVPEY GCVVNLRKTVVNFPVEDEALGGTAFVQMPAHGLFPWCGLLLDTRTLEVQSDYSSYARTSIRASLTFNRGFKAGRNMRRKLFGVLRLKCHS LFLDLQVNSLQTVCTNIYKILLLQAYRFHACVLQLPFHQQVWKNPTFFLRVISDTASLCYSILKAKNAGMSLGAKGAAGPLPSEAVQWLC -------------------------------------------------------------- >In-frame_ENST00000556492_ENST00000296820_TCGA-27-1835-01A_NAA30_chr14_57866601_+_TERT_chr5_1282739_length(transcript)=3303nt_BP=1105nt AAACTTTACCCGGCCTAACAGCTGAGGCGCTTTACGGCGACGGCGGCTGAGTGAGAACCTTGGCGGCTGTGGAGGCTGCCGCGGCTGCGA AGGAGGCGGCGGCGGTGGCGGAGGAAGAGGAGTGGCGGCAGCGGCGGCGGGGACCCGTGCGGGGATGGCGGAGGTACCGCCTGGGCCTAG CAGCCTCCTCCCACCACCAGCACCTCCGGCCCCGGCGGCGGTCGAGCCCCGCTGTCCCTTCCCGGCGGGGGCCGCCCTCGCCTGCTGCAG CGAGGACGAGGAGGACGACGAAGAGCACGAAGGCGGCGGCAGCAGGAGCCCGGCGGGCGGAGAGTCGGCGACGGTGGCGGCCAAGGGGCA TCCGTGCCTCCGCTGCCCTCAGCCGCCGCAGGAGCAGCAGCAGCTCAACGGATTGATTAGCCCCGAACTGCGGCACCTCCGGGCGGCCGC CTCCCTCAAGAGCAAGGTCCTGAGCGTAGCAGAGGTGGCCGCGACCACAGCCACCCCTGACGGAGGCCCCAGAGCGACTGCAACAAAAGG AGCCGGGGTACACTCGGGCGAGAGGCCCCCTCACTCCCTCTCTAGTAATGCAAGAACTGCGGTCCCCAGCCCGGTGGAGGCAGCGGCGGC GAGCGATCCCGCGGCGGCCCGCAATGGACTGGCCGAGGGCACCGAGCAGGAGGAGGAGGAGGAAGACGAGCAGGTGCGGCTGCTGTCTTC GTCCCTGACCGCCGACTGCAGCTTAAGAAGCCCTTCGGGCAGGGAGGTTGAGCCTGGGGAGGATCGGACGATACGATATGTCCGATATGA ATCCGAGCTACAAATGCCCGATATCATGAGACTGATCACCAAAGATCTGTCCGAACCCTACTCCATTTATACCTATAGATATTTTATCCA CAACTGGCCACAGCTGTGCTTCTTGGCCATGGTAGGGGAGGAGTGTGTAGGTGCCATCGTTTGCAAGTTGGATATGCACAAAAAGATGTT CCGCAGAGGTTATATAGCCATGTTAGCCGTGGATTCCAAATACAGGAGAAATGGCATTGGTACTAACTTGGTTAAGAAAGCTATATATGC CATGGTTGAGGGAGACTGTGATGAGGGGTTGGCTGTGTTCCGGCCGCAGAGCACCGTCTGCGTGAGGAGATCCTGGCCAAGTTCCTGCAC TGGCTGATGAGTGTGTACGTCGTCGAGCTGCTCAGGTCTTTCTTTTATGTCACGGAGACCACGTTTCAAAAGAACAGGCTCTTTTTCTAC CGGAAGAGTGTCTGGAGCAAGTTGCAAAGCATTGGAATCAGACAGCACTTGAAGAGGGTGCAGCTGCGGGAGCTGTCGGAAGCAGAGGTC AGGCAGCATCGGGAAGCCAGGCCCGCCCTGCTGACGTCCAGACTCCGCTTCATCCCCAAGCCTGACGGGCTGCGGCCGATTGTGAACATG GACTACGTCGTGGGAGCCAGAACGTTCCGCAGAGAAAAGAGGGCCGAGCGTCTCACCTCGAGGGTGAAGGCACTGTTCAGCGTGCTCAAC TACGAGCGGGCGCGGCGCCCCGGCCTCCTGGGCGCCTCTGTGCTGGGCCTGGACGATATCCACAGGGCCTGGCGCACCTTCGTGCTGCGT GTGCGGGCCCAGGACCCGCCGCCTGAGCTGTACTTTGTCAAGGTGGATGTGACGGGCGCGTACGACACCATCCCCCAGGACAGGCTCACG GAGGTCATCGCCAGCATCATCAAACCCCAGAACACGTACTGCGTGCGTCGGTATGCCGTGGTCCAGAAGGCCGCCCATGGGCACGTCCGC AAGGCCTTCAAGAGCCACGTCCTACGTCCAGTGCCAGGGGATCCCGCAGGGCTCCATCCTCTCCACGCTGCTCTGCAGCCTGTGCTACGG CGACATGGAGAACAAGCTGTTTGCGGGGATTCGGCGGGACGGGCTGCTCCTGCGTTTGGTGGATGATTTCTTGTTGGTGACACCTCACCT CACCCACGCGAAAACCTTCCTCAGGACCCTGGTCCGAGGTGTCCCTGAGTATGGCTGCGTGGTGAACTTGCGGAAGACAGTGGTGAACTT CCCTGTAGAAGACGAGGCCCTGGGTGGCACGGCTTTTGTTCAGATGCCGGCCCACGGCCTATTCCCCTGGTGCGGCCTGCTGCTGGATAC CCGGACCCTGGAGGTGCAGAGCGACTACTCCAGCTATGCCCGGACCTCCATCAGAGCCAGTCTCACCTTCAACCGCGGCTTCAAGGCTGG GAGGAACATGCGTCGCAAACTCTTTGGGGTCTTGCGGCTGAAGTGTCACAGCCTGTTTCTGGATTTGCAGGTGAACAGCCTCCAGACGGT GTGCACCAACATCTACAAGATCCTCCTGCTGCAGGCGTACAGGTTTCACGCATGTGTGCTGCAGCTCCCATTTCATCAGCAAGTTTGGAA GAACCCCACATTTTTCCTGCGCGTCATCTCTGACACGGCCTCCCTCTGCTACTCCATCCTGAAAGCCAAGAACGCAGGGATGTCGCTGGG GGCCAAGGGCGCCGCCGGCCCTCTGCCCTCCGAGGCCGTGCAGTGGCTGTGCCACCAAGCATTCCTGCTCAAGCTGACTCGACACCGTGT CACCTACGTGCCACTCCTGGGGTCACTCAGGACAGCCCAGACGCAGCTGAGTCGGAAGCTCCCGGGGACGACGCTGACTGCCCTGGAGGC CGCAGCCAACCCGGCACTGCCCTCAGACTTCAAGACCATCCTGGACTGATGGCCACCCGCCCACAGCCAGGCCGAGAGCAGACACCAGCA GCCCTGTCACGCCGGGCTCTACGTCCCAGGGAGGGAGGGGCGGCCCACACCCAGGCCCGCACCGCTGGGAGTCTGAGGCCTGAGTGAGTG TTTGGCCGAGGCCTGCATGTCCGGCTGAAGGCTGAGTGTCCGGCTGAGGCCTGAGCGAGTGTCCAGCCAAGGGCTGAGTGTCCAGCACAC CTGCCGTCTTCACTTCCCCACAGGCTGGCGCTCGGCTCCACCCCAGGGCCAGCTTTTCCTCACCAGGAGCCCGGCTTCCACTCCCCACAT AGGAATAGTCCATCCCCAGATTCGCCATTGTTCACCCCTCGCCCTGCCCTCCTTTGCCTTCCACCCCCACCATCCAGGTGGAGACCCTGA GAAGGACCCTGGGAGCTCTGGGAATTTGGAGTGACCAAAGGTGTGCCCTGTACACAGGCGAGGACCCTGCACCTGGATGGGGGTCCCTGT >In-frame_ENST00000556492_ENST00000296820_TCGA-27-1835-01A_NAA30_chr14_57866601_+_TERT_chr5_1282739_length(amino acids)=376AA_start in transcript=46_stop in transcript=1176 MSENLGGCGGCRGCEGGGGGGGGRGVAAAAAGTRAGMAEVPPGPSSLLPPPAPPAPAAVEPRCPFPAGAALACCSEDEEDDEEHEGGGSR SPAGGESATVAAKGHPCLRCPQPPQEQQQLNGLISPELRHLRAAASLKSKVLSVAEVAATTATPDGGPRATATKGAGVHSGERPPHSLSS NARTAVPSPVEAAAASDPAAARNGLAEGTEQEEEEEDEQVRLLSSSLTADCSLRSPSGREVEPGEDRTIRYVRYESELQMPDIMRLITKD LSEPYSIYTYRYFIHNWPQLCFLAMVGEECVGAIVCKLDMHKKMFRRGYIAMLAVDSKYRRNGIGTNLVKKAIYAMVEGDCDEGLAVFRP -------------------------------------------------------------- |
Top |
Fusion Gene PPI Analysis for NAA30-TERT |
Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in |
Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
- Retained PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
- Lost PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
- Retained PPIs, but lost function due to frame-shift fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs for NAA30-TERT |
Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.8 2021-05-08) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
Related Diseases for NAA30-TERT |
Diseases associated with fusion partners. (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Tgene | TERT | C3151443 | DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 2 | 11 | CTD_human;GENOMICS_ENGLAND;UNIPROT |
Tgene | TERT | C3553617 | PULMONARY FIBROSIS AND/OR BONE MARROW FAILURE, TELOMERE-RELATED, 1 | 8 | CTD_human;GENOMICS_ENGLAND;UNIPROT |
Tgene | TERT | C0002874 | Aplastic Anemia | 6 | CTD_human;GENOMICS_ENGLAND;UNIPROT |
Tgene | TERT | C0265965 | Dyskeratosis Congenita | 5 | CTD_human;GENOMICS_ENGLAND |
Tgene | TERT | C1800706 | Idiopathic Pulmonary Fibrosis | 5 | CTD_human;ORPHANET |
Tgene | TERT | C4721508 | Hamman-Rich Disease | 5 | CTD_human |
Tgene | TERT | C4721509 | Usual Interstitial Pneumonia | 5 | CTD_human |
Tgene | TERT | C4721952 | Familial Idiopathic Pulmonary Fibrosis | 5 | CTD_human |
Tgene | TERT | C2239176 | Liver carcinoma | 4 | CTD_human |
Tgene | TERT | C0023467 | Leukemia, Myelocytic, Acute | 3 | CTD_human;GENOMICS_ENGLAND |
Tgene | TERT | C1148551 | X-Linked Dyskeratosis Congenita | 3 | CTD_human |
Tgene | TERT | C1956346 | Coronary Artery Disease | 3 | CTD_human;GENOMICS_ENGLAND |
Tgene | TERT | C0017638 | Glioma | 2 | CTD_human |
Tgene | TERT | C0024121 | Lung Neoplasms | 2 | CTD_human |
Tgene | TERT | C0025202 | melanoma | 2 | CTD_human;GENOMICS_ENGLAND |
Tgene | TERT | C0030297 | Pancreatic Neoplasm | 2 | CTD_human |
Tgene | TERT | C0033578 | Prostatic Neoplasms | 2 | CTD_human |
Tgene | TERT | C0242379 | Malignant neoplasm of lung | 2 | CTD_human |
Tgene | TERT | C0259783 | mixed gliomas | 2 | CTD_human |
Tgene | TERT | C0334488 | Clear cell sarcoma of kidney | 2 | ORPHANET |
Tgene | TERT | C0346647 | Malignant neoplasm of pancreas | 2 | CTD_human |
Tgene | TERT | C0348890 | Aplastic anemia, idiopathic | 2 | ORPHANET |
Tgene | TERT | C0376358 | Malignant neoplasm of prostate | 2 | CTD_human |
Tgene | TERT | C0555198 | Malignant Glioma | 2 | CTD_human |
Tgene | TERT | C1846142 | HOYERAAL-HREIDARSSON SYNDROME | 2 | CTD_human;GENOMICS_ENGLAND;ORPHANET |
Tgene | TERT | C3554574 | MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 9 | 2 | CTD_human;GENOMICS_ENGLAND |
Tgene | TERT | C0005684 | Malignant neoplasm of urinary bladder | 1 | CTD_human |
Tgene | TERT | C0005695 | Bladder Neoplasm | 1 | CTD_human |
Tgene | TERT | C0006142 | Malignant neoplasm of breast | 1 | CTD_human |
Tgene | TERT | C0006826 | Malignant Neoplasms | 1 | CTD_human |
Tgene | TERT | C0007131 | Non-Small Cell Lung Carcinoma | 1 | CTD_human |
Tgene | TERT | C0007873 | Uterine Cervical Neoplasm | 1 | CTD_human |
Tgene | TERT | C0010054 | Coronary Arteriosclerosis | 1 | CTD_human |
Tgene | TERT | C0010314 | Cri-du-Chat Syndrome | 1 | CTD_human |
Tgene | TERT | C0022658 | Kidney Diseases | 1 | CTD_human |
Tgene | TERT | C0023448 | Lymphoid leukemia | 1 | CTD_human |
Tgene | TERT | C0023473 | Myeloid Leukemia, Chronic | 1 | CTD_human |
Tgene | TERT | C0023903 | Liver neoplasms | 1 | CTD_human |
Tgene | TERT | C0024115 | Lung diseases | 1 | GENOMICS_ENGLAND |
Tgene | TERT | C0024141 | Lupus Erythematosus, Systemic | 1 | CTD_human |
Tgene | TERT | C0027022 | Myeloproliferative disease | 1 | CTD_human |
Tgene | TERT | C0027651 | Neoplasms | 1 | CTD_human |
Tgene | TERT | C0027819 | Neuroblastoma | 1 | CTD_human |
Tgene | TERT | C0035126 | Reperfusion Injury | 1 | CTD_human |
Tgene | TERT | C0040136 | Thyroid Neoplasm | 1 | CTD_human |
Tgene | TERT | C0041696 | Unipolar Depression | 1 | PSYGENET |
Tgene | TERT | C0085786 | Hamman-Rich syndrome | 1 | ORPHANET |
Tgene | TERT | C0086692 | Benign Neoplasm | 1 | CTD_human |
Tgene | TERT | C0151468 | Thyroid Gland Follicular Adenoma | 1 | CTD_human |
Tgene | TERT | C0178416 | Hypoplastic anemia | 1 | CTD_human |
Tgene | TERT | C0206686 | Adrenocortical carcinoma | 1 | CTD_human |
Tgene | TERT | C0235874 | Disease Exacerbation | 1 | CTD_human |
Tgene | TERT | C0242380 | Libman-Sacks Disease | 1 | CTD_human |
Tgene | TERT | C0345904 | Malignant neoplasm of liver | 1 | CTD_human |
Tgene | TERT | C0549473 | Thyroid carcinoma | 1 | CTD_human |
Tgene | TERT | C0678222 | Breast Carcinoma | 1 | CTD_human |
Tgene | TERT | C0919267 | ovarian neoplasm | 1 | CTD_human |
Tgene | TERT | C1140680 | Malignant neoplasm of ovary | 1 | CTD_human |
Tgene | TERT | C1257931 | Mammary Neoplasms, Human | 1 | CTD_human |
Tgene | TERT | C1269683 | Major Depressive Disorder | 1 | PSYGENET |
Tgene | TERT | C1368275 | Pigmented Basal Cell Carcinoma | 1 | CTD_human |
Tgene | TERT | C1458155 | Mammary Neoplasms | 1 | CTD_human |
Tgene | TERT | C2314896 | Familial Atypical Mole Melanoma Syndrome | 1 | ORPHANET |
Tgene | TERT | C3151444 | DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE, 4 | 1 | GENOMICS_ENGLAND |
Tgene | TERT | C4048328 | cervical cancer | 1 | CTD_human |
Tgene | TERT | C4704874 | Mammary Carcinoma, Human | 1 | CTD_human |
Tgene | TERT | C4721806 | Carcinoma, Basal Cell | 1 | CTD_human |